23-year-old female, type 1 diabetes since 5 years of age. A1C elevated to 8.9% after usually having A1Cs in the 6-7 range. Came to see me at the end of our workday after wearing LibrePro (Blinded CGM) to go over her food/insulin/glucose/activity/etc. patterns. First thing she said to me was that she had a Dexcom but hasn't worn it because battery in transmitter was out for the past 6 months. She told me she really hasn't been checking her glucose on a regular basis at all.
Read More »Production Assistant, Diabetes In Control
International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #73: Regulation of Glucose Metabolism in Liver Part 9 of 11
Glucose phosphorylation as a therapeutic target for diabetes: Early experiments using genetic overexpression of glucokinase in liver of rodent models showed promise for the protection against hyperglycemia during diabetes, spawning the development of glucokinase activators. These drugs interact with allosteric sites of glucokinase, thus promoting a conformation that exposes the catalytic domain and potentiates the activity of the enzyme.
Read More »Link Between Insulin Resistance and Cognitive Dysfunction
Could diabetes cause increased rates of dementia?
Read More »Should You Use Metformin For Type 1’s?
This study is the first retrospective, long-term analysis of metformin as adjuvant therapy to insulin in patients with T1DM.
Read More »Decreasing Risk of Lower Extremity Amputation
What should you add to prevent a loss of limb?
Read More »Sweetening with Stevia
This sweet treat may be future aid in diabetes treatment.
Read More »Novel Antihypertensive Lowered HbA1c in People with Diabetes
Medication showed significant reduction in risk for cardiovascular death, hospitalization for worsening heart failure.
Read More »Metformin Linked to Increased Risk of Dementia and Parkinson’s Disease
Study finds connection between duration of therapy in senior patients and development of neurodegenerative disease.
Read More »Diagnosing Fatty Liver
When diagnosing suspected nonalcoholic fatty liver disease (NAFLD), hepatic steatosis and inflammation with hepatocellular injury is an indication of which one of the following? A. Nonalcoholic fatty liver (NAFL) B. Nonalcoholic steatohepatitis (NASH) C. Both of the above D. None of the above Follow the link to see the correct answer!
Read More »It’s Like Riding a Bike
When was the last time you rode a bike? Follow the link to see how you compare to your colleagues!
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.